- Home
- DAWN vs SNBR Comparison
DAWN vs SNBR Comparison
Compare DAWN & SNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- SNBR
- Stock Information
- Founded
- DAWN 2018
- SNBR 1987
- Country
- DAWN United States
- SNBR United States
- Employees
- DAWN N/A
- SNBR N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- SNBR Home Furnishings
- Sector
- DAWN Health Care
- SNBR Consumer Discretionary
- Exchange
- DAWN Nasdaq
- SNBR Nasdaq
- Market Cap
- DAWN 1.3B
- SNBR 261.1M
- IPO Year
- DAWN 2021
- SNBR 1998
- Fundamental
- Price
- DAWN $12.79
- SNBR $16.74
- Analyst Decision
- DAWN Strong Buy
- SNBR Hold
- Analyst Count
- DAWN 7
- SNBR 3
- Target Price
- DAWN $36.17
- SNBR $12.83
- AVG Volume (30 Days)
- DAWN 937.9K
- SNBR 368.6K
- Earning Date
- DAWN 10-30-2024
- SNBR 10-30-2024
- Dividend Yield
- DAWN N/A
- SNBR N/A
- EPS Growth
- DAWN N/A
- SNBR N/A
- EPS
- DAWN N/A
- SNBR N/A
- Revenue
- DAWN $101,953,000.00
- SNBR $1,734,997,000.00
- Revenue This Year
- DAWN N/A
- SNBR N/A
- Revenue Next Year
- DAWN $36.10
- SNBR $1.68
- P/E Ratio
- DAWN N/A
- SNBR N/A
- Revenue Growth
- DAWN N/A
- SNBR N/A
- 52 Week Low
- DAWN $11.94
- SNBR $8.13
- 52 Week High
- DAWN $18.07
- SNBR $20.75
- Technical
- Relative Strength Index (RSI)
- DAWN 39.97
- SNBR 47.89
- Support Level
- DAWN $12.26
- SNBR $18.36
- Resistance Level
- DAWN $12.81
- SNBR $20.00
- Average True Range (ATR)
- DAWN 0.52
- SNBR 1.35
- MACD
- DAWN -0.05
- SNBR -0.26
- Stochastic Oscillator
- DAWN 28.94
- SNBR 26.86
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.